AbbVievsMedtronic

ABBV and MDT stock compared: price, dividend, valuation and results, from SEC filings.

MDT

Medtronic plc.

$104.00

Value $133B

+1.12%
MDT's page

AbbVie (ABBV) has a market value of $528B and Medtronic (MDT) $133B. Over the last year, with dividends, ABBV moved +32.7% and MDT +12.1%. The P/E is 51.3 for ABBV and 25.5 for MDT. Dividend yield: ABBV 2.32%, MDT 2.75%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$528B

    MDT$133B

    ABBV is 4.0 times MDT

  • Revenue, 12 months

    ABBV$66.0B

    MDT$37.5B

    ABBV is 1.8 times MDT

  • Net income, 12 months

    ABBV$10.3B

    MDT$5.2B

    ABBV is 2.0 times MDT

  • Operating margin

    ABBV32.2%

    MDT18.1%

    14.1 points apart

  • ROIC

    ABBV25.7%

    MDT7.0%

    18.7 points apart

  • P/E

    ABBV51.3

    MDT25.5

    ABBV is 2.0 times MDT

  • Dividend yield

    ABBV2.3%

    MDT2.8%

    0.5 points apart

  • 5-year return

    ABBV+206.3%

    MDT+3.8%

    202.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+206.3%

MDT+3.8%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsMDTWith dividends
1 year since November 14, 2025+32.7%Price +28.8%+12.1%Price +8.5%
3 years since November 16, 2023+139.4%+33.8% a yearPrice +116.5%+53.2%+15.3% a yearPrice +38.9%
5 years since November 15, 2021+206.3%+25.1% a yearPrice +156.2%+3.8%+0.7% a yearPrice -11.5%
10 years since November 16, 2016+631.3%+22.0% a yearPrice +386.5%+67.4%+5.3% a yearPrice +28.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieMDTMedtronic

Valuation

ABBVMDT
Valuation
Price$298.72$104.00
Market value$528B$133B
Enterprise value (EV)$598B$152B
P/E51.325.5
P/E, 5-year median57.028.0
P/B–2.7
EV/EBIT28.222.5
Free cash flow yield3.6%4.6%

Results and growth

ABBVMDT
Results and growth
Revenue, 12 months$66.0B$37.5B
Net income, 12 months$10.3B$5.2B
Free cash flow, 12 months$18.9B$6.1B
Earnings per share, 12 months$5.81$4.07
Revenue growth, year on year8.6%8.4%
Revenue growth a year, past+5.9%over 5 years+3.8%over 5 years
EPS growth a year, past-2.8%over 5 years+7.0%over 5 years

Margins and returns on capital

ABBVMDT
Margins and returns on capital
Gross margin73.7%65.0%
Operating margin32.2%18.1%
Net margin15.7%13.9%
ROIC25.7%7.0%
ROE–10.7%

Balance sheet

ABBVMDT
Balance sheet
Cash$10.8B$8.8B
Total debt$80.9B$28.2B
Net debt / EBITDA3.22.0
Interest cover7.1×9.4×

Dividends and buybacks

ABBVMDT
Dividends and buybacks
Dividend yield2.3%2.8%
Dividend per share, 12 months$6.92$2.86
Dividend growth a year, past+6.6%over 5 years+4.1%over 5 years
Buyback yield0.2%0.8%
Shareholder yield2.5%3.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or MDT

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Medtronic?

By market value, AbbVie ($528B) is about 4.0 times Medtronic ($133B), at today's prices.

How did ABBV and MDT stock do over the last 10 years?

Since November 16, 2016, ABBV's price moved +386.5% and MDT's +28.6%. With dividends: ABBV +631.3% (+22.0% a year), MDT +67.4% (+5.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or MDT?

The dividend yield at today's price is 2.32% for AbbVie and 2.75% for Medtronic. Over the last twelve months they paid $6.92 and $2.86 per share.

What is the P/E of ABBV and MDT?

At today's price, the P/E is 51.3 for ABBV and 25.5 for MDT. The median of the last five years was 57.0 and 28.0, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or Medtronic?

Over the last twelve months, the net margin was 15.7% for AbbVie and 13.9% for Medtronic, and the operating margin 32.2% and 18.1%. Revenue was $66.0B and $37.5B.

Which is the better investment, AbbVie or Medtronic?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.